SSY GROUP(02005): Indigo green has been approved for registration as an active pharmaceutical ingredient for use in marketed preparations.

The SSY Group (02005) announced that their indocyanine green has been approved by the China National Medical Products Administration for registration as a raw material for use in marketed formulations. Indocyanine green can be used for diagnosing various liver diseases such as cirrhosis, liver fibrosis, chronic hepatitis, occupational and drug-induced liver diseases to understand the extent of liver damage and its reserve function; It can also be used for choroidal angiography to determine the location of choroidal diseases.